89bio Reports Positive Topline Data From Extended Phase 2b ENLIVEN Trial Of Pegozafermin

RTTNews | 610 days ago
89bio Reports Positive Topline Data From Extended Phase 2b ENLIVEN Trial Of Pegozafermin

(RTTNews) - Biopharmaceutical company 89bio, Inc. (ETNB) announced Monday positive topline data from the blinded extension phase of its Phase 2b ENLIVEN trial evaluating treatment with pegozafermin in patients with nonalcoholic steatohepatitis (NASH).

At week 48, both the 30mg weekly (QW) and 44mg every-two-week (Q2W) dosing schedules of pegozafermin demonstrated statistically significant improvements across key markers of liver health.

The benefits observed at week 48 were consistent with the results observed at week 24, indicating sustained benefits over time.

Patients in ENLIVEN continued in a blinded extension phase for an additional 24 weeks (Extension Phase) past the primary endpoint at week 24 (Main Study), for a total treatment period of 48 weeks.

read more
UK Mortgage Approvals At 3-Month High

UK Mortgage Approvals At 3-Month High

UK mortgage approvals rose to a three-month high in June and consumer credit increased notably, official data revealed on Tuesday. Approvals for house purchases increased to a three-month high of 64,167 in June from 63,288 in May, the Bank of England reported. Approvals were above economists' forecast of 63,000.
RTTNews | 8 minutes ago
DAX Up Nearly 1.5% On All-round Buying

DAX Up Nearly 1.5% On All-round Buying

German stocks are up sharply on Tuesday with investors shrugging off tariff concerns and focusing on earnings updates and awaiting the Federal Reserve's monetary policy announcement due on Wednesday.
RTTNews | 27 minutes ago
Sensex, Nifty Recoup Losses To End Notably Higher

Sensex, Nifty Recoup Losses To End Notably Higher

Indian shares reversed course to end higher on Tuesday after an American top official said that more negotiations are required between the United States and India to seal a trade deal.
RTTNews | 37 minutes ago
Philips Shares Jump As FY25 Margin Outlook Raised, Despite Weak Q2

Philips Shares Jump As FY25 Margin Outlook Raised, Despite Weak Q2

Shares of Royal Philips N.V. were surging around 10 percent in the morning trading in Amsterdam as well as in the pre-market activity on the NYSE, after the Dutch consumer electronics giant on Tuesday raised its fiscal 2025 margin outlook, benefited by lower tariff impact, and maintained fiscal 2025 comparable sales growth view. Meanwhile, the company issued weak margin outlook for its third quart
RTTNews | 47 minutes ago
U.S. Dollar Rises As Traders Focus On U.S. Data, Trade Talks

U.S. Dollar Rises As Traders Focus On U.S. Data, Trade Talks

The U.S. dollar strengthened against other major currencies in the European session on Tuesday, as traders awaited the outcome of ongoing U.S.-China talks in Stockholm, key U.S. economic indicators and upcoming Fed and BoJ rate decisions. Top economic officials from both nations held over five hours of negotiations on Monday to resolve longstanding economic disputes and lay the groundwork ahead of a leaders' summit in the autumn.
RTTNews | 51 minutes ago
Asian Shares Mixed As US-China Talks Continue

Asian Shares Mixed As US-China Talks Continue

Asian stocks ended Tuesday's session on a mixed note as investors looked past the U.S.-EU trade deal and awaited the outcome of ongoing U.S.-China talks in Stockholm.
RTTNews | 2h 21min ago